Weiliang Zhu Selected Research

Breast Neoplasms (Breast Cancer)

1/2024	Ciliogenesis-associated Kinase 1 Promotes Breast Cancer Cell Proliferation and Chemoresistance via Phosphorylating ERK1.
1/2021	EPHA5 mutation predicts the durable clinical benefit of immune checkpoint inhibitors in patients with lung adenocarcinoma.
10/2018	DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weiliang Zhu Research Topics

Disease

54	Neoplasms (Cancer) 04/2024 - 05/2004
20	Multiple Myeloma 12/2023 - 11/2016
10	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 06/2014
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2023 - 11/2016
6	Alzheimer Disease (Alzheimer's Disease) 10/2019 - 03/2005
5	Lymphoma (Lymphomas) 02/2024 - 01/2017
5	Infections 01/2019 - 04/2010
5	Melanoma (Melanoma, Malignant) 01/2017 - 09/2012
5	Inflammation (Inflammations) 01/2017 - 01/2005
4	Carcinogenesis 09/2023 - 05/2008
4	COVID-19 01/2023 - 01/2021
4	Asthma (Bronchial Asthma) 01/2023 - 01/2005
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2012
4	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 11/2016
4	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2010
4	Atherosclerosis 01/2019 - 06/2014
4	Influenza in Birds (Avian Flu) 08/2012 - 06/2006
3	Breast Neoplasms (Breast Cancer) 01/2024 - 10/2018
3	Choroidal Neovascularization 12/2022 - 01/2022
3	Adenocarcinoma of Lung 01/2021 - 01/2020
3	Lung Neoplasms (Lung Cancer) 01/2021 - 03/2019
3	T-Cell Leukemia (Leukemia, T Cell) 06/2020 - 01/2017
3	Nasopharyngeal Carcinoma 08/2017 - 04/2011
3	Prostatic Neoplasms (Prostate Cancer) 04/2017 - 08/2014
3	Insulin Resistance 01/2017 - 11/2010
2	Fibrosis (Cirrhosis) 05/2024 - 03/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2021
2	Pneumonia (Pneumonitis) 01/2023 - 01/2013
2	Retinal Degeneration 06/2022 - 02/2016
2	Carcinoma (Carcinomatosis) 05/2022 - 04/2014
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2020 - 07/2018
2	Hypertension (High Blood Pressure) 03/2019 - 05/2008
2	Obesity 01/2019 - 12/2008
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2018 - 08/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 06/2014
2	Amyloid Plaque 06/2007 - 04/2005
2	Rupture 04/2007 - 08/2005
1	Hypertrophy 05/2024
1	Myocardial Infarction 05/2024

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2005
7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
7	pterostilbeneIBA 01/2021 - 11/2016
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 05/2008
5	DCZ3301IBA 12/2020 - 01/2017
4	Blood Glucose (Blood Sugar)IBA 01/2017 - 09/2006
4	Peptide Hydrolases (Proteases)FDA Link 08/2014 - 03/2005
3	ErbB Receptors (EGF Receptor)IBA 03/2024 - 05/2004
3	Phosphotransferases (Kinase)IBA 01/2024 - 04/2011
3	Adenosine Triphosphate (ATP)IBA 12/2023 - 08/2005
3	DCZ0358IBA 12/2023 - 01/2018
3	Bortezomib (Velcade)FDA Link 11/2023 - 06/2020
3	Retinaldehyde (Retinal)IBA 06/2022 - 02/2016
3	VaccinesIBA 01/2022 - 06/2013
3	LigandsIBA 01/2021 - 06/2007
3	EnzymesIBA 10/2019 - 09/2006
3	Amyloid (Amyloid Fibrils)IBA 10/2019 - 06/2007
3	Sorafenib (BAY 43-9006)FDA Link 03/2019 - 01/2013
3	LipidsIBA 01/2019 - 11/2010
3	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 08/2017 - 08/2014
3	Small Interfering RNA (siRNA)IBA 03/2015 - 06/2014
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 10/2010 - 03/2005
2	Trastuzumab (Herceptin)FDA Link 01/2024 - 10/2018
2	Etoposide (VP 16)FDA LinkGeneric 12/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 12/2022 - 12/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022 - 12/2022
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 05/2022 - 03/2016
2	Sincalide FDA Link 01/2022 - 08/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 01/2015
2	Therapeutic UsesIBA 10/2021 - 01/2020
2	SiliconesIBA 01/2021 - 01/2020
2	RafoxanideIBA 02/2020 - 01/2019
2	Histone Deacetylase InhibitorsIBA 01/2020 - 05/2017
2	PanobinostatIBA 01/2020 - 05/2017
2	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2020 - 04/2017
2	Oncogene Proteins (Oncogene Protein)IBA 10/2018 - 05/2016
2	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 08/2018 - 11/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 08/2018 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 01/2017 - 11/2016
2	Fatty Acid-Binding ProteinsIBA 01/2017 - 01/2015
2	celastrolIBA 05/2016 - 02/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 01/2013
2	VemurafenibIBA 04/2014 - 01/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2013 - 04/2013
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2013 - 10/2012
2	Insulin (Novolin)FDA Link 01/2013 - 11/2010
2	Zanamivir (Relenza)FDA Link 08/2012 - 10/2006
2	N-AcetylglucosaminyltransferasesIBA 08/2012 - 10/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2011 - 05/2004
2	Neuraminidase (Sialidase)IBA 09/2006 - 06/2006
2	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 05/2006 - 03/2005
1	CollagenIBA 05/2024
1	Atrial Natriuretic Factor (ANF)IBA 05/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024

Therapy/Procedure

28	Therapeutics 01/2024 - 05/2008
5	Drug Therapy (Chemotherapy) 01/2023 - 06/2014
5	Immunotherapy 01/2023 - 01/2020
4	Intraperitoneal Injections 04/2020 - 11/2016
3	Lasers (Laser) 12/2022 - 01/2022
3	Radiotherapy 03/2019 - 08/2014
1	Precision Medicine 03/2024